{"id":"W3129575296","doi":"10.1002/cjp2.203","title":"Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer","year":2021,"lang":"en","type":"review","venue":"The Journal of Pathology Clinical Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Chugai Pharmaceutical; Genentech; Astellas Pharma; National Institute for Health and Care Research; Incyte; Ipsen; Clovis Oncology; Royal Marsden NHS Foundation Trust; University of Chicago; Bristol-Myers Squibb; AstraZeneca; American Society of Clinical Oncology; Sanofi; Les Laboratories Pierre Fabre; Amgen; Pfizer","keywords":"Olaparib; Medicine; Prostate cancer; PARP inhibitor; Molecular diagnostics; Bioinformatics; Cancer; Computational biology; Oncology; Internal medicine; Poly ADP ribose polymerase; Gene; Polymerase; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01962556,0.0002139273,0.001756347,0.0004890052,0.0002114099,0.0000351135,0.0001013453,0.000277425,0.00006707982],"category_scores_gemma":[0.04812433,0.0001267284,0.0003439376,0.000744785,0.0005905513,0.0001371153,0.00005650652,0.003008109,0.000004868029],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000520241,"about_ca_system_score_gemma":0.00546764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007154316,"about_ca_topic_score_gemma":0.00001407825,"domain_scores_codex":[0.9896482,0.006589996,0.002259237,0.0003347695,0.0007530453,0.0004148128],"domain_scores_gemma":[0.954518,0.03924166,0.001493873,0.0003552899,0.004241132,0.0001500287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00400781,0.004242449,0.004784812,0.007995705,0.001934496,0.008601844,0.0009327968,0.0002143907,0.000003902349,0.0003332475,0.01081239,0.9561362],"study_design_scores_gemma":[0.1264941,0.1133741,0.02435147,0.3187568,0.03233461,0.1030549,0.003195194,0.001586968,0.00006192439,0.027606,0.2458125,0.003371403],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01183498,0.9768957,0.0008715143,0.004722572,0.000625933,0.004859179,0.0000898709,0.00002469731,0.00007554017],"genre_scores_gemma":[0.001050298,0.9531183,0.04490464,0.0002279363,0.0002409272,0.0002716667,0.00005778405,0.00005338241,0.00007510947],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9527647,"threshold_uncertainty_score":0.999292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5958416978514839,"score_gpt":0.6270654534842924,"score_spread":0.03122375563280855,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}